Home

Helen Torley, President and CEO: Halozyme Therapeutics HALO Sell · Filed 25/12/01

Trade details

Type
Insider sale
Amount
$712,915.06
Shares · price
10,406 sh · $68.51 a share
Held after
714,882 sh
Trade date
25/12/01
Filed
25/12/01
Days to filing
0 days

Sold 1.4% of holdings

Share of holding sold
1.4%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/01~25/12/31

Helen Torley's recent trades

  • Helen Torley

    Planned sale10b5-1 planHalozyme Therapeutics

    $23.7M

    Filed 08/17

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $1.1M

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $875.6K

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $425.1K

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $369.2K

    Filed 06/03